Low-Dose Sublingual Zolpidem Tartrate is Associated with Dose-Related Improvement in Sleep Onset and Duration in Insomnia Characterized by Middle-of-the-Night (MOTN) Awakenings

Ítems similars

• Novel Sublingual Low-Dose Zolpidem Tablet Reduces Latency to Sleep Onset following Spontaneous Middle-of-the-Night Awakening in Insomnia in a Randomized, Double-Blind, Placebo-Controlled, Outpatient Study
  per: Roth, Thomas, et al.
  Publicat: (2013)
• Fast-Acting Sublingual Zolpidem for Middle-of-the-Night Wakefulness
  per: Joseph V. Pergolizzi, et al.
  Publicat: (2014-01-01)
• Fast-Acting Sublingual Zolpidem for Middle-of-the-Night Wakefulness
  per: Pergolizzi, Joseph V., et al.
  Publicat: (2014)
• Residual Effects of Low-Dose Sublingual Zolpidem on Highway Driving Performance the Morning after Middle-of-the-Night Use
  per: Vermeeren, Annemiek, et al.
  Publicat: (2014)
• New approaches in the treatment of short term and middle of the night insomnia: emerging evidence for a role for sublingual zolpidem tablets
  per: Ownby, Raymond L
  Publicat: (2010)